Washington’s Flawed New Law: Part 3

Washington’s Flawed New Law: Part 3
House Speaker Nancy Pelosi (D-Calif.) speaks during a press conference about prescription drugs and lower health care costs at Southeast Health Center Clinic in San Francisco on Aug. 24, 2022. Pelosi met with health care professionals and local residents who will benefit from provisions in the recently passed Inflation Reduction Act that will lower health care and prescription drug costs. Justin Sullivan/Getty Images
Milton Ezrati
Updated:
0:00
Commentary
This article is the last of a three-part series on the new Inflation Reduction Act (IRA), which takes up the proposed new health care rules in which the government lodges its inflation reduction claims. The first part of this series examined the law’s lavish spending on green initiatives. The second part assessed its dubious revenue claims.
Milton Ezrati
Milton Ezrati
Author
Milton Ezrati is a contributing editor at The National Interest, an affiliate of the Center for the Study of Human Capital at the University at Buffalo (SUNY), and chief economist for Vested, a New York-based communications firm. Before joining Vested, he served as chief market strategist and economist for Lord, Abbett & Co. He also writes frequently for City Journal and blogs regularly for Forbes. His latest book is "Thirty Tomorrows: The Next Three Decades of Globalization, Demographics, and How We Will Live."
Related Topics